Skip to main content
Signal8

Manby Frederick R

SEC insider (Form 3/4/5 filer). CIK 0002156015. Chief Technology Officer at Iambic Therapeutics, Inc. (IAM). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 14, 2026. Located in SAN DIEGO, CA.

Companies Manby Frederick R has filed insider reports for

  • Iambic Therapeutics, Inc. (IAM): Director, Officer, Chief Technology Officer
Manby Frederick R profile photo

Manby Frederick R

CIK: 0002156015

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Iambic Therapeutics, Inc. logo
IAM

Iambic Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Iambic Therapeutics, Inc. logo
    IAM

    Iambic Therapeutics, Inc.

    Oct 14, 2026
    Award
    Direct
    132.2K shares-

1-1 of 1